Skip to main content

Table 3 Meta-analysis of the association of HSD17B13 rs72613567: TA allelic variant and liver disease susceptibility

From: Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis

Liver disease Number of studies Relevance test Heterogeneity test Publication
OR(95% CI)   Z Pvalue I2 Q Phel Pegger
HCC compared with CLD (allelic model) 5 0.766(0.682–0.860) 4.51 0.000 45.8 7.38 0.117 0.378 1.03
HCC compared with CLD (additive model) 3 0.755(0.645–0.885) 3.47 0.001 0 1.91 0.384 0.845 -0.25
HCC compared with healthy controls (allelic model) 3 0.648(0.429–0.979) 2.06 0.039 62.1 5.28 0.071 0.033 19.01
NAFLD compared with NON-NAFLD (allelic model) 5 0.669(0.524–0.856) 3.20 0.001 68.9 12.87 0.012 0.280 0.800
NAFLD compared with healthy controls (allelic model) 3 0.600(0.464–0.777) 3.89 0.000 50.3 4.02 0.134 0.060 0.963